4.8 Article

A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura

Journal

NATURE MEDICINE
Volume 16, Issue 10, Pages 1157-U1501

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2216

Keywords

-

Funding

  1. Genome Canada
  2. Genome Quebec
  3. Emerillon Therapeutics
  4. Wellcome Trust
  5. Pfizer
  6. Medical Research Council (UK)
  7. Natural Sciences and Engineering Research Council of Canada
  8. MRC [G0601887] Funding Source: UKRI
  9. Medical Research Council [G0601887] Funding Source: researchfish

Ask authors/readers for more resources

Migraine with aura is a common, debilitating, recurrent headache disorder associated with transient and reversible focal neurological symptoms(1). A role has been suggested for the two-pore domain (K2P) potassium channel, TWIK-related spinal cord potassium channel (TRESK, encoded by KCNK18), in pain pathways and general anaesthesia(2). We therefore examined whether TRESK is involved in migraine by screening the KCNK18 gene in subjects diagnosed with migraine. Here we report a frameshift mutation, F139WfsX24, which segregates perfectly with typical migraine with aura in a large pedigree. We also identified prominent TRESK expression in migraine-salient areas such as the trigeminal ganglion. Functional characterization of this mutation demonstrates that it causes a complete loss of TRESK function and that the mutant subunit suppresses wild-type channel function through a dominant-negative effect, thus explaining the dominant penetrance of this allele. These results therefore support a role for TRESK in the pathogenesis of typical migraine with aura and further support the role of this channel as a potential therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available